Protein tyrosine phosphatase 1B inhibits adipocyte differentiation and mediates TNFα action in obesity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 8, 2013, Pages 1368-1376

  Song, Dan Dan ^a,b,c   Chen, Yue ^a   Li, Zhi Yong ^b   Guan, Yun Feng ^b   Zou, Da Jin ^a   Miao, Chao Yu ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Adipocyte differentiation; Adipogenesis; Obesity; Protein tyrosine phosphatase 1B; Tumor necrosis factor alpha

Indexed keywords

FAS ANTIGEN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROTEIN TYROSINE PHOSPHATASE 1B; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR NECROSIS FACTOR ALPHA; DIFFERENTIATION ANTIGEN; PTPN1 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET; DOWN REGULATION; ENZYME INHIBITION; GENETIC TRANSFECTION; IN VITRO STUDY; LENTIVIRINAE; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; UPREGULATION; WHITE ADIPOSE TISSUE; ANIMAL; CELL STRAIN 3T3; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; METABOLISM; MOUSE MUTANT; PATHOLOGY;

LENTIVIRUS; MUS;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; MALE; MICE; MICE, OBESE; OBESITY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883023198     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.05.006     Document Type: Article

References (55)

1. N. Dube, M.L. Tremblay, Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer, Biochim. Biophys. Acta 1754 (2005) 108-117. (Pubitemid 41797691)
2. M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A.L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C.C. Chan, C. Ramachandran, M.J. Gresser, M.L. Tremblay, B.P. Kennedy, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene, Science 283 (1999) 1544-1548.
3. L.D. Klaman, O. Boss, O.D. Peroni, J.K. Kim, J.L. Martino, J.M. Zabolotny, N. Moghal, M. Lubkin, Y.B. Kim, A.H. Sharpe, A. Stricker-Krongrad, G.I. Shulman, B.G. Neel, B.B. Kahn, Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice, Mol. Cell. Biol. 20 (2000) 5479-5489. (Pubitemid 30482885)
4. K.K. Bence, M. Delibegovic, B. Xue, C.Z. Gorgun, G.S. Hotamisligil, B.G. Neel, B.B. Kahn, Neuronal PTP1B regulates body weight, adiposity and leptin action, Nat. Med. 12 (2006) 917-924. (Pubitemid 44175143)
5. M. Delibegovic, K.K. Bence, N. Mody, E.G. Hong, H.J. Ko, J.K. Kim, B.B. Kahn, B.G. Neel, Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B, Mol. Cell. Biol. 27 (2007) 7727-7734. (Pubitemid 350033677)
6. M. Delibegovic, D. Zimmer, C. Kauffman, K. Rak, E.G. Hong, Y.R. Cho, J.K. Kim, B.B. Kahn, B.G. Neel, K.K. Bence, Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress, Diabetes 58 (2009) 590-599.
7. R. Banno, D. Zimmer, B.C. De Jonghe, M. Atienza, K. Rak, W. Yang, K.K. Bence, PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice, J. Clin. Invest. 120 (2010) 720-734.
8. S.C. Ruffolo, P.K. Forsell, X. Yuan, S. Desmarais, J. Himms-Hagen, W. Cromlish, K.K. Wong, B.P. Kennedy, Basal activation of p70S6K results in adipose-specific insulin resistance in protein-tyrosine phosphatase 1B-/-mice, J. Biol. Chem. 282 (2007) 30423-30433. (Pubitemid 350035220)
9. C. Owen, A. Czopek, A. Agouni, L. Grant, R. Judson, E.K. Lees, G.D. McIlroy, O. Goransson, A. Welch, K.K. Bence, B.B. Kahn, B.G. Neel, N. Mody, M. Delibegovic, Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis, PLoS One 7 (2012) e32700.
10. F. Ahmad, R.V. Considine, B.J. Goldstein, Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects, J. Clin. Invest. 95 (1995) 2806-2812.
11. F. Ahmad, R.V. Considine, T.L. Bauer, J.P. Ohannesian, C.C. Marco, B.J. Goldstein, Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue, Metabolism 46 (1997) 1140-1145. (Pubitemid 27418501)
12. A. Cheung, J. Kusari, D. Jansen, D. Bandyopadhyay, A. Kusari, M. Bryer-Ash, Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus, J. Lab. Clin. Med. 134 (1999) 115-123. (Pubitemid 29375440)
13. X. Wu, V.E. Hardy, J.I. Joseph, S. Jabbour, K. Mahadev, L. Zhu, B.J. Goldstein, Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition, Metabolism 52 (2003) 705-712. (Pubitemid 36896303)
14. N. Hoggard, A. Agouni, N. Mody, M. Delibegovic, Serum levels of RBP4 and adipose tissue levels of PTP1B are increased in obese men resident in northeast Scotland without associated changes in ER stress response genes, Int. J. Gen. Med. 5 (2012) 403-411.
15. C. Gayet, V. Leray, M. Saito, B. Siliart, P. Nguyen, The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs, Br. J. Nutr. 98 (2007) 497-503. (Pubitemid 47277257)
16. S. Rodriguez-Cuenca, S. Carobbio, V.R. Velagapudi, N. Barbarroja, J.M. Moreno-Navarrete, F.J. Tinahones, J.M. Fernandez-Real, M. Oresic, A. Vidal-Puig, Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility, Mol. Cell. Biol. 32 (2012) 1555-1565.
17. A. Kashiwagi, D. Mott, C. Bogardus, S. Lillioja, G.M. Reaven, J.E. Foley, The effects of short-term overfeeding on adipocyte metabolism in Pima Indians, Metabolism 34 (1985) 364-370. (Pubitemid 15066006)
18. E. Danforth Jr., Failure of adipocyte differentiation causes type II diabetes mellitus? Nat. Genet. 26 (2000) 13.
19. L. Heilbronn, S.R. Smith, E. Ravussin, Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus, Int. J. Obes. Relat. Metab. Disord. 28 (Suppl. 4) (2004) S12-S21. (Pubitemid 40143844)
20. A. Guilherme, J.V. Virbasius, V. Puri, M.P. Czech, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes, Nat. Rev. Mol. Cell Biol. 9 (2008) 367-377. (Pubitemid 351574198)
21. N. Ouchi, J.L. Parker, J.J. Lugus, K. Walsh, Adipokines in inflammation and metabolic disease, Nat. Rev. Immunol. 11 (2011) 85-97.
22. K.H. Pietilainen, K. Kannisto, E. Korsheninnikova, A. Rissanen, J. Kaprio, E. Ehrenborg, A. Hamsten, H. Yki-Jarvinen, Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins, J. Clin. Endocrinol. Metab. 91 (2006) 2776-2781. (Pubitemid 44024650)
23. G.S. Hotamisligil, Inflammation and metabolic disorders, Nature 444 (2006) 860-867. (Pubitemid 46024993)
24. E.P. Araujo, C.T. De Souza, M. Ueno, D.E. Cintra, M.B. Bertolo, J.B. Carvalheira, M.J. Saad, L.A. Velloso, Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes, Endocrinology 148 (2007) 5991-5997. (Pubitemid 350146162)
25. A. Cartier, I. Lemieux, N. Almeras, A. Tremblay, J. Bergeron, J.P. Despres, Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men, J. Clin. Endocrinol. Metab. 93 (2008) 1931-1938. (Pubitemid 351656540)
26. M. Kudo, A. Sugawara, A. Uruno, K. Takeuchi, S. Ito, Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/enhancer-binding protein delta during the early stage of adipocyte differentiation, Endocrinology 145 (2004) 4948-4956. (Pubitemid 39551112)
27. B. Gustafson, U. Smith, Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes, J. Biol. Chem. 281 (2006) 9507-9516. (Pubitemid 43864668)
28. P. Isakson, A. Hammarstedt, B. Gustafson, U. Smith, Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation, Diabetes 58 (2009) 1550-1557.
29. J. Ye, J.M. Gimble, Regulation of stem cell differentiation in adipose tissue by chronic inflammation, Clin. Exp. Pharmacol. Physiol. 38 (2011) 872-878.
30. S. Miranda, Á. González-Rodríguez, J. Revuelta-Cervantes, C.M. Rondinone, Á.M. Valverde, Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli, Cell. Signal. 22 (2010) 645-659.
31. K. Matsuo, A. Bettaieb, N. Nagata, I. Matsuo, H. Keilhack, F.G. Haj, Regulation of brown fat adipogenesis by protein tyrosine phosphatase 1B, PLoS One 6 (2011) e16446.
32. C.M. Rondinone, J.M. Trevillyan, J. Clampit, R.J. Gum, C. Berg, P. Kroeger, L. Frost, B.A. Zinker, R. Reilly, R. Ulrich, M. Butler, B.P. Monia, M.R. Jirousek, J.F. Waring, Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis, Diabetes 51 (2002) 2405-2411. (Pubitemid 34827388)
33. J.F. Waring, R. Ciurlionis, J.E. Clampit, S. Morgan, R.J. Gum, R.A. Jolly, P. Kroeger, L. Frost, J. Trevillyan, B.A. Zinker, M. Jirousek, R.G. Ulrich, C.M. Rondinone, PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat, Mol. Cell. Endocrinol. 203 (2003) 155-168. (Pubitemid 36627596)
34. J. Xu, L. Li, Z. Qian, J. Hong, S. Shen, W. Huang, Reduction of PTP1B by RNAi upregulates the activity of insulin controlled fatty acid synthase promoter, Biochem. Biophys. Res. Commun. 329 (2005) 538-543. (Pubitemid 40311778)
35. S. Boubekeur, N. Boute, P. Pagesy, V. Zilberfarb, N. Christeff, T. Issad, A new highly efficient substrate-trapping mutant of protein tyrosine phosphatase 1B (PTP1B) reveals full autoactivation of the insulin receptor precursor, J. Biol. Chem. 286 (2011) 19373-19380.
36. P. Wang, T.Y. Xu, Y.F. Guan, D.F. Su, G.R. Fan, C.Y. Miao, Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide, Cardiovasc. Res. 81 (2009) 370-380.
37. P. Wang, C. Bai, Q.Y. Xu, T.Y. Xu, D.F. Su, J. Sassard, C.Y. Miao, Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats, Clin. Exp. Pharmacol. Physiol. 37 (2010) 894-899.
38. P. Wang, T.Y. Xu, Y.F. Guan, W.W. Tian, B. Viollet, Y.C. Rui, Q.W. Zhai, D.F. Su, C.Y. Miao, Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway, Ann. Neurol. 69 (2011) 360-374.
39. P. Wang, F.J. Yang, H. Du, Y.F. Guan, T.Y. Xu, X.W. Xu, D.F. Su, C.Y. Miao, Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction, Mol. Med. 17 (2011) 523-532.
40. P. Wang, Y.F. Guan, H. Du, Q.W. Zhai, D.F. Su, C.Y. Miao, Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia, Autophagy 8 (2012) 77-87.
41. P. Wang, R.Y. Zhang, J. Song, Y.F. Guan, T.Y. Xu, H. Du, B. Viollet, C.Y. Miao, Loss of AMP-activated protein kinase-alpha2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle, Diabetes 61 (2012) 1051-1061.
42. L. Fajas, J.C. Fruchart, J. Auwerx, Transcriptional control of adipogenesis, Curr. Opin. Cell Biol. 10 (1998) 165-173. (Pubitemid 28174758)
43. R.L. Peterson, L. Casciotti, L. Block, M.E. Goad, Z. Tong, J.T. Meehan, R.A. Jordan, M.P. Vinlove, V.R. Markiewicz, C.A. Weed, A.J. Dorner, Mechanistic toxicogenomic analysis of WAY-144122 administration in Sprague-Dawley rats, Toxicol. Appl. Pharmacol. 196 (2004) 80-94. (Pubitemid 38393696)
44. D.V. Erbe, S. Wang, Y.L. Zhang, K. Harding, L. Kung, M. Tam, L. Stolz, Y. Xing, S. Furey, A. Qadri, L.D. Klaman, J.F. Tobin, Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms, Mol. Pharmacol. 67 (2005) 69-77. (Pubitemid 40069967)
45. B.R. Bhattarai, B. Kafle, J.S. Hwang, S.W. Ham, K.H. Lee, H. Park, I.O. Han, H. Cho, Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-gamma activators, Bioorg. Med. Chem. Lett. 20 (2010) 6758-6763.
46. R. Hernandez, T. Teruel, M. Lorenzo, Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes, Diabetologia 46 (2003) 1618-1628. (Pubitemid 38005324)
47. Y. Wu, J.P. Ouyang, K. Wu, S.S. Wang, C.Y. Wen, Z.Y. Xia, Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats, Br. J. Pharmacol. 146 (2005) 234-243. (Pubitemid 43079963)
48. C.L. Venable, E.U. Frevert, Y.B. Kim, B.M. Fischer, S. Kamatkar, B.G. Neel, B.B. Kahn, Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation, J. Biol. Chem. 275 (2000) 18318-18326. (Pubitemid 30414787)
49. E.D. Rosen, O.A. MacDougald, Adipocyte differentiation from the inside out, Nat. Rev. Mol. Cell Biol. 7 (2006) 885-896. (Pubitemid 44871415)
50. G. Xu, C. Arregui, J. Lilien, J. Balsamo, PTP1B modulates the association of beta-catenin with N-cadherin through binding to an adjacent and partially overlapping target site, J. Biol. Chem. 277 (2002) 49989-49997. (Pubitemid 36014450)
51. C. Ortiz, L. Caja, E. Bertran, A. Gonzalez-Rodriguez, A.M. Valverde, I. Fabregat, P. Sancho, Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-beta (TGF-beta)-induced suppressor effects in hepatocytes, J. Biol. Chem. 287 (2012) 15263-15274.
52. S.M. Brichard, C.J. Bailey, J.C. Henquin, Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate, Diabetes 39 (1990) 1326-1332. (Pubitemid 20372219)
53. M.Z. Xu, A.Z. Zhang, X.R. Li, W. Xu, L.W. Shen, Effects of vanadate on the activities of mice glucokinase and hexokinase, J. Zhejiang Univ.(Sci.) 5 (2004) 1245-1248.
54. J. Wu, L.J. Yang, D.J. Zou, Rosiglitazone attenuates tumor necrosis factor-alpha-induced protein-tyrosine phosphatase-1B production in HepG2 cells, J. Endocrinol. Invest. 35 (2012) 28-34.
55. J.M. Zabolotny, Y.B. Kim, L.A. Welsh, E.E. Kershaw, B.G. Neel, B.B. Kahn, Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo, J. Biol. Chem. 283 (2008) 14230-14241.